Evidence map›Paper›PMID 24977202›Full record

ReviewTheScientificWorldJournal2014

Multiple sclerosis and pregnancy: current considerations.

Ioan Buraga, Roxana-Elena Popovici

Open access · goldAbstract readReview
In one paragraph

Review in TheScientificWorldJournal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  5. Contraception for women with multiple sclerosis: Guidance for healthcare providers.Multiple sclerosis (Houndmills, Basingstoke, England) · 2017
    Review
  6. Natalizumab in Multiple Sclerosis: Long-Term Management.International journal of molecular sciences · 2017
    Review
  7. Neurological Disorders Complicating Pregnancy - Focus on Obstetric Outcome.Journal of clinical and diagnostic research : JCDR · 2016
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ioan BuragaHead of Neurology, "Carol Davila" University of Medicine and Pharmacy, Colentina Clinical Hospital, No. 19-21 Stefan cel Mare Avenue, 020125 Bucharest, Romania.ORCID 0000-0002-5223-7929
Roxana-Elena PopoviciDepartment of Neurology, Colentina Clinical Hospital, No. 19-21 Stefan cel Mare Avenue, 020125 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROSpitalul Clinic Colentina · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis is the most common neurological disease of young adults that causes major disability. In Romania, it is estimated that this disease has a prevalence of 35-40 per 100,000 inhabitants. It is a disease that begins at the age of 20-40 years and is 2-3 times more common in women than in men. More than half of patients with MS develop the disease in their fertile period of life; therefore, MS patients use contraceptive methods while being under our treatment. Since several therapeutic options have been implemented with good efficiency in the disease stabilization, increasingly more patients begin to wonder about the possibility of having a child and about the possible risks of pregnancy. The evolution during pregnancy and the lactation period has been favorable, with lower relapses and side effects comparable to those in the general population. In addition, babies born to mothers with MS have not had a significantly different mean gestational age or birth weight compared to babies born to healthy mothers.

Indexed as

FemaleHumansImmunologic FactorsIncidenceInternationalityMultiple SclerosisPregnancyPregnancy ComplicationsPregnancy OutcomeRisk FactorsTreatment OutcomeImmunologic Factors

Identifiers

PMID24977202
PMCPMC3997075
OpenAlexW2001556188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.